证券代码：300285 证券简称：国瓷材料 公告编号：2025-054 第六届董事会第一次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 山东国瓷功能材料股份有限公司（以下简称"公司"或"国瓷材料"）于 2025 年 9 月 11 日以邮件形式发出了《山东国瓷功能材料股份有限公司第六届董事会第一 次会议的通知》。本次会议于 2025 年 9 月 14 日在公司会议室以通讯会议的方式召 开。会议应出席董事 9 名，实际出席董事 9 名，公司高级管理人员列席了会议。本次 会议的召集、召开符合《中华人民共和国公司法》及《公司章程》的有关规定，会议 合法有效。本次会议由 9 名董事共同推举张曦先生主持。 本次董事会对以下议案内容进行了表决，表决情况如下： 山东国瓷功能材料股份有限公司 1.00 审议通过了《关于选举第六届董事会董事长的议案》 经全体董事审议，同意选举张曦先生为第六届董事会董事长，同时选举张曦先生 为代表公司执行公司事务的董事、担任公司法定代表人，任期自本次董事会审议通过 之日起至第六届董事会任期届满之日止。本议案已经公司董事会提名委员会审议通 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东国瓷功能材料股份有限公司（以下简称"公司"）于 2025 年 9 月 5 日 召开 2025 年第一次临时股东会，审议通过了《关于公司董事会换届选举暨提名 第六届董事会非独立董事候选人的议案》《关于公司董事会换届选举暨提名第六 届董事会独立董事候选人的议案》等议案，选举产生了第六届董事会董事，与公 司职工代表大会选举产生的职工代表董事王晓红女士，共同组成公司第六届董事 会，任期自公司 2025 年第一次临时股东会选举通过之日起三年。 证券代码：300285 证券简称：国瓷材料 公告编号：2025-055 山东国瓷功能材料股份有限公司 关于完成董事会换届选举及聘任高级管理人员、证券事务代 表的公告 2025 年 9 月 14 日，公司召开第六届董事会第一次会议，选举产生了第六届 董事会董事长、副董事长、各专门委员会委员、聘任了公司高级管理人员及证券 事务代表。现将相关情况公告如下： 一、第六届董事会组成情况 （一）董事会成员 1、非独立董事：张曦（董事长）、张兵（副董事长）、秦建民、宋锡滨、 陈汉、王晓红（职工 ...

山东国瓷功能材料股份有限公司 第四条 公司拟披露的信息存在不确定性，属于临时性商业秘密等情形，及 时披露可能损害公司利益或者误导投资者的，可以暂缓披露。 山东国瓷功能材料股份有限公司 信息披露暂缓与豁免制度 （2025 年 9 月） 第一章 总 则 第一条 为规范山东国瓷功能材料股份有限公司（以下简称"公司"）信息披 露暂缓与豁免行为，确保公司及相关信息披露义务人（以下简称"信息披露义务 人"）依法合规地履行信息披露义务，保护投资者的合法权益，根据《中华人民 共和国公司法》《中华人民共和国证券法》《上市公司信息披露管理办法》《深圳 证券交易所创业板股票上市规则》（以下简称"《股票上市规则》"）《上市公司信 息披露暂缓与豁免管理规定》以及有关法律法规、规章和《山东国瓷功能材料股 份有限公司章程》（以下简称"《公司章程》"）《信息披露管理制度》的规定，结 合公司信息披露工作的实际情况，制定本制度。 第二条 公司按照《股票上市规则》及交易所其他相关业务规则的规定，办 理信息披露暂缓、豁免业务的，适用本制度。 第三条 公司拟披露的信息存在《股票上市规则》及交易所其他相关业务规 则中规定的可暂缓、豁免披露情形的，由公司 ...

Core Viewpoint - Guocera Materials has shown a significant increase in stock price and trading activity, indicating positive market sentiment and potential growth opportunities in the high-end functional ceramic materials sector [1][2]. Financial Performance - As of June 30, Guocera Materials reported a revenue of 2.154 billion yuan, representing a year-on-year growth of 10.29%, while the net profit attributable to shareholders was 332 million yuan, with a slight increase of 0.38% [2]. - The company has distributed a total of 870 million yuan in dividends since its A-share listing, with 398 million yuan distributed over the past three years [3]. Stock Market Activity - On September 15, Guocera Materials' stock price rose by 2.08% to 24.10 yuan per share, with a trading volume of 167 million yuan and a turnover rate of 0.84%, leading to a total market capitalization of 24.029 billion yuan [1]. - Year-to-date, the stock price has increased by 43.10%, with a 0.21% rise over the last five trading days, an 11.99% increase over the last 20 days, and a 48.77% increase over the last 60 days [1]. Shareholder Structure - As of June 30, the number of shareholders increased to 48,200, a rise of 14.53%, while the average circulating shares per person decreased by 12.68% to 17,470 shares [2]. - The largest circulating shareholder is Hong Kong Central Clearing Limited, holding 55.921 million shares, a decrease of 1.4332 million shares from the previous period [3].

Group 1 - The stock price of Guoci Materials (300285) closed at 23.62 yuan on September 12, 2025, down by 3.63% with a turnover rate of 3.23% and a trading volume of 272,000 shares, resulting in a transaction amount of 645 million yuan [1] - On September 12, the net outflow of main funds was 38.23 million yuan, while retail investors saw a net inflow of 44.03 million yuan [2][3] - The vice president of Guoci Materials, Xu Shaomei, was ordered to rectify by the Shandong Securities Regulatory Bureau for failing to perform other duties as required by law [2][3]

Investment Rating - The report maintains a "Recommended" rating for the chemical industry [1] Core Insights - The chemical industry in China is expected to undergo a revaluation due to anti-involution measures, which may lead to a significant slowdown in global chemical capacity expansion. This shift could enhance the cash flow and dividend yield of Chinese chemical companies, transforming them from cash-consuming entities to profit-generating ones [6][29] - The demand for chromium salts is anticipated to rise significantly due to increased orders for gas turbines and commercial aircraft engines in Europe and the US, leading to a projected shortfall of 250,000 tons by 2028, which is about 23% of the total annual production [6] - The report highlights four key investment opportunities: low-cost expansion, improving industry conditions, new materials, and high dividend yields from state-owned enterprises [7][8] Summary by Sections Recent Performance - The basic chemical sector has shown a performance increase of 51.0% over the past 12 months, compared to 42.5% for the CSI 300 index [4] Investment Recommendations - The report emphasizes the potential for low-cost expansion in major companies such as Wanhua Chemical, Hualu Hengsheng, and others, alongside sectors like tires and fertilizers [7] - It also points out the improving conditions in various segments, including chromium salts, phosphate rock, and agricultural chemicals [8] Key Products Analysis - Recent price increases were noted for acrylic acid and esters, with butyl acrylate priced at 7,600 RMB/ton, reflecting a 3.40% increase [10] - The report also mentions the price of polymer MDI in East China at 15,550 RMB/ton, up by 1.97% [10] Company Tracking and Earnings Forecast - The report provides a detailed earnings forecast for key companies, indicating a positive outlook for many, with several companies rated as "Buy" [30]

Investment Rating - The report maintains a "Positive" rating for the chemical industry [6][12]. Core Insights - The macroeconomic judgment indicates that non-OPEC countries are expected to lead an increase in oil production, with a significant overall supply growth anticipated. Global GDP growth is projected to remain at 2.8%, with stable oil demand, although the growth rate may slow due to tariff policies [6][7]. - The expectation of a Federal Reserve interest rate cut is likely to boost demand during the peak season of September and October. Additionally, the leakage incident of GFL R32 in India may enhance China's export opportunities [6][12]. - The report highlights the ongoing investigation into anti-dumping practices against imported semiconductor chips from the U.S., which may benefit domestic semiconductor materials [6][12]. Summary by Sections Macroeconomic Analysis - Oil supply is expected to increase significantly, driven by non-OPEC production, while demand remains stable despite potential slowdowns due to tariffs. Geopolitical factors, including U.S.-China tariff relief and the Russia-Ukraine situation, are influencing oil prices [6][7]. - Coal prices are anticipated to stabilize at a low level, and natural gas export facilities in the U.S. may accelerate, leading to lower import costs [6][7]. Chemical Sector Configuration - The report suggests a strategic focus on four areas: textile and apparel chain, agricultural chemicals, export chain, and sectors benefiting from "de-involution" policies. Specific companies are recommended for investment based on their market positions and growth potential [6][12]. Key Material Focus - Emphasis is placed on the importance of self-sufficiency in key materials, particularly in semiconductor and panel materials, with specific companies highlighted for their potential in these sectors [6][12]. Price Trends - Recent data indicates fluctuations in various chemical prices, with PTA prices down by 0.3% and MEG down by 2.0%. The report notes that the overall industrial product PPI has shown a year-on-year decline of 2.9% [12][13][16]. Company Valuations - A detailed valuation table is provided, showcasing various companies in the agricultural chemicals and chemical sectors, with ratings ranging from "Buy" to "Increase" based on their market performance and projected earnings [20].

Group 1 - The company announced the establishment of a joint venture focused on the research and industrialization of solid-state electrolyte materials [2] - The joint venture was approved during the company's fifth board meeting held on August 17, 2025 [2] - The joint venture has completed its business registration and obtained a business license from the Dongying Economic and Technological Development Zone Market Supervision Administration [2]

本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 山东国瓷功能材料股份有限公司（以下简称"公司"）于2025年8月17日召 开第五届董事会第二十三次会议，审议通过了《关于对外投资设立合资公司的 议案》，同意公司与王琰先生共同出资设立合资公司，专注于固态电解质材料 的研发与产业化，具体内容详见公司于2025年8月19日在中国证监会指定创业板 信息披露网站上披露的《关于对外投资设立合资公司的公告》（公告编号： 2025-033）。 山东国瓷功能材料股份有限公司 关于合资公司完成工商注册登记的公告 证券代码：300285 证券简称：国瓷材料 公告编号：2025-053 近日，该合资公司完成工商注册登记，并取得东营经济技术开发区市场监 督管理局颁发的《营业执照》，相关登记信息如下： 特此公告！ 山东国瓷功能材料股份有限公司 董事会 2025 年 9 月 12 日 8、经营范围：一般项目：新材料技术研发；电子专用材料研发；电子专用 材料制造；电子专用材料销售；新型陶瓷材料销售；表面功能材料销售；新型 膜材料制造；新型膜材料销售；特种陶瓷制品制造；特种陶瓷制品销售；高性 能 ...

Core Insights - The article discusses the evolution of policies supporting the development of the biomedical materials industry in China, highlighting a shift from basic research support to industrialization, innovation-driven growth, and high-quality development [1][3]. Policy Overview - Since 2015, multiple government departments, including the State Council and the National Health Commission, have issued various policies to support and regulate the biomedical materials industry, focusing on technology development, industry upgrades, quality standards, and centralized procurement [3][4]. - Key policies include the 2024 notification on centralized procurement of high-value medical consumables, aimed at enhancing procurement efficiency and reducing costs [4][5]. - The "14th Five-Year Plan" emphasizes the development of high-end medical devices and key technologies, aiming to improve supply capabilities and address gaps in high-end medical equipment [9][10]. Development Goals - The focus is on technological innovation in high-end implantable products, such as biodegradable vascular stents and artificial joints, as well as new materials like recombinant collagen and biodegradable materials [8][9]. - The government aims to optimize approval processes, promote bulk procurement, and enhance collaboration among academia, industry, and healthcare to boost competitiveness and domestic production levels [8][10]. - By 2025, the goal is to achieve comprehensive coverage of DRG/DIP payment methods in all eligible medical institutions, ensuring a more efficient healthcare financing system [10]. Regional Policies - Various provinces have introduced policies to promote the biomedical materials industry, with a focus on centralized procurement for orthopedic implants and other high-value medical consumables [12][13]. - Cities like Beijing and Shanghai are encouraging the development of new biomedical materials and technologies, including advanced manufacturing techniques and 3D bioprinting [13][14]. - The policies aim to strengthen the local manufacturing capabilities and foster innovation in the biomedical materials sector [14][17].